SG171472A1 - Substituted aniline derivatives - Google Patents

Substituted aniline derivatives

Info

Publication number
SG171472A1
SG171472A1 SG200718941-8A SG2007189418A SG171472A1 SG 171472 A1 SG171472 A1 SG 171472A1 SG 2007189418 A SG2007189418 A SG 2007189418A SG 171472 A1 SG171472 A1 SG 171472A1
Authority
SG
Singapore
Prior art keywords
aniline derivatives
substituted aniline
derivatives
pharmaceutically acceptable
general formula
Prior art date
Application number
SG200718941-8A
Other languages
English (en)
Inventor
Daniel Rodriguez Greve
Mario Rottlaender
William Patrick Watson
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG171472A1 publication Critical patent/SG171472A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG200718941-8A 2003-03-14 2004-03-12 Substituted aniline derivatives SG171472A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300392 2003-03-14

Publications (1)

Publication Number Publication Date
SG171472A1 true SG171472A1 (en) 2011-06-29

Family

ID=58707220

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200718941-8A SG171472A1 (en) 2003-03-14 2004-03-12 Substituted aniline derivatives

Country Status (12)

Country Link
US (1) US20060167087A1 (ko)
KR (1) KR20050117563A (ko)
CN (1) CN1759099A (ko)
AR (1) AR043507A1 (ko)
CL (1) CL2004000488A1 (ko)
EA (1) EA200501299A1 (ko)
IS (1) IS7924A (ko)
NO (1) NO20054721L (ko)
NZ (1) NZ541242A (ko)
SG (1) SG171472A1 (ko)
UA (1) UA81799C2 (ko)
ZA (1) ZA200505357B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799832B2 (en) * 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
JP2011525538A (ja) * 2008-06-24 2011-09-22 バレアント プハルマセウトイカルス インターナショナル カリウムチャネルモジュレーターとして有用なベンジルオキシアニリド誘導体
US20130108687A1 (en) 2010-05-21 2013-05-02 Universitat Fur Bodenkultur Wien Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
US20130210883A1 (en) 2010-05-21 2013-08-15 Johannes Grillari Lipase inhibitors
WO2014114649A1 (en) * 2013-01-22 2014-07-31 Technische Universität Graz Lipase inhibitors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386452A1 (de) * 1989-02-10 1990-09-12 BASF Aktiengesellschaft Diphenylheteroalkylderivate, ihre Herstellung und daraus hergestellte Arzneimittel und Kosmetika
EP0515684A1 (en) * 1990-02-14 1992-12-02 Chugai Seiyaku Kabushiki Kaisha Inhibitor of denatured ldl formation
WO2001009612A1 (de) * 1999-08-03 2001-02-08 Arzneimittelwerk Dresden Gmbh Modulatorische bindungsstelle an kaliumkanälen zum screening
EP1369420A1 (en) * 2002-06-06 2003-12-10 Aventis Pharma Deutschland GmbH Inhibitors of the GPib - vWF interaction

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386452A1 (de) * 1989-02-10 1990-09-12 BASF Aktiengesellschaft Diphenylheteroalkylderivate, ihre Herstellung und daraus hergestellte Arzneimittel und Kosmetika
EP0515684A1 (en) * 1990-02-14 1992-12-02 Chugai Seiyaku Kabushiki Kaisha Inhibitor of denatured ldl formation
WO2001009612A1 (de) * 1999-08-03 2001-02-08 Arzneimittelwerk Dresden Gmbh Modulatorische bindungsstelle an kaliumkanälen zum screening
EP1369420A1 (en) * 2002-06-06 2003-12-10 Aventis Pharma Deutschland GmbH Inhibitors of the GPib - vWF interaction

Also Published As

Publication number Publication date
AR043507A1 (es) 2005-08-03
CN1759099A (zh) 2006-04-12
ZA200505357B (en) 2006-12-27
CL2004000488A1 (es) 2005-01-07
IS7924A (is) 2005-06-30
EA200501299A1 (ru) 2006-02-24
NZ541242A (en) 2009-01-31
NO20054721L (no) 2005-10-13
US20060167087A1 (en) 2006-07-27
KR20050117563A (ko) 2005-12-14
UA81799C2 (uk) 2008-02-11

Similar Documents

Publication Publication Date Title
MY147786A (en) Substituted morpholine and thiomorpholine derivatives
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
NO20025590D0 (no) Fenylglycin-derivater
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
SE0202463D0 (sv) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
ATE302775T1 (de) Carbolinderivate
MXPA05010174A (es) Derivados de indol e indolina sustituidos.
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE346067T1 (de) Carbolinderivate
MXPA05009282A (es) Derivados de anilina sustituidos.
NO20054721L (no) Substituerte anilinderivater
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
TW200628153A (en) Novel compounds
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
SI1845780T1 (sl) Uporaba derivatov metilfenidata
ATE259813T1 (de) Triazolopyrimidinderivate
GB0308201D0 (en) Novel compounds
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
EP1434762A4 (en) 4'-METHANSULFONYLBIPHENYL DERIVATIVES AS HIGH-DETECTIVE CYCLOOXYGENASE-2 INHIBITORS
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts